Marriage Counselors in Ankeny, IA Accepting Medicare

7 Marriage Counselors found. Showing 1 - 7

Mrs. Christina Marie Hill, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 225 Nw School St, Ankeny, IA 50023 Phone: 515-964-5003    Fax: 515-225-4016

Dr. Mary E Meyer, PHD, LMFT, CSAT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 602 Se Delaware Ave, Ankeny, IA 50021 Phone: 515-705-0174

Mrs. Linda M Vinchattle, MA, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 6950 Ne 14th St Ste 36, Ankeny, IA 50023 Phone: 612-296-0152

Lauren Mackenzie Martin, MA, TLMFT Marriage & Family Therapist Medicare: Medicare Enrolled Practice Location: 501 Sw Ankeny Rd, Ankeny, IA 50023 Phone: 515-289-2272

Jordan K Plummer, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 501 Sw Ankeny Rd, Ankeny, IA 50023 Phone: 515-289-2272    Fax: 515-289-0126

Mrs. Amy Jane Halls, LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 S Ankeny Blvd Ste 101, Ankeny, IA 50023 Phone: 515-989-8266    Fax: 515-686-8003

Kelsi Vi Kennison, M.S., LMFT Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 213 N Ankeny Blvd Ste 100, Ankeny, IA 50023 Phone: 515-337-1764

News Archive

Baxalta announces initial results from ADYNOVATE Phase 3 trial for treatment of hemophilia patients

Baxalta Incorporated, a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today announced initial results from a Phase 3 clinical trial of ADYNOVATE [Antihemophilic Factor (Recombinant), PEGylated], an extended circulating half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A based on ADVATE [Antihemophilic Factor (Recombinant)].

Patterson Companies fourth quarter consolidated sales increase 9% to $883,819,000

Patterson Companies, Inc. today reported consolidated sales of $883,819,000 for the fourth quarter of fiscal 2011 ended April 30, an increase of 9% from $812,762,000 in the year-earlier quarter.

Fatty acid-binding protein 4 plays an important role in kidney stone formation

Kidney stone disease has a high prevalence worldwide, ranging up to 13% in North America, 9% in Europe, and 5% in Asia. They are painful for patients, often lead to surgery, and impart a significant economic impact.

Relative of the celebrated COX-2 inhibitor celecoxib is tough tumor fighter

A close structural relative of the celebrated COX-2 inhibitor celecoxib (brand name: Celebrex) is a potent tumor fighter, able to wipe out tumor cells that are resistant to conventional chemotherapies, according to an interdisciplinary team of researchers from the University of Southern California.

Read more Medical News

› Verified 9 days ago